AI in Heart Failure and Structural Heart Disease

Rosu AI an initiative by Sun Pharma, presents its latest issue: “AI in Cardiology: The Clinical Foundation.”Artificial intelligence (AI) is rapidly transforming the landscape of cardiovascular medicine by enabling the analysis of large, complex datasets and uncovering patterns beyond conventional clinical approaches. In an era where cardiology is becoming increasingly data-intensive, AI-driven tools are supporting improved risk prediction, early disease detection, and more precise, individualized treatment strategies.In this edition of Rosu AI, we bring together key concepts, clinical applications, and future perspectives to help clinicians understand the evolving role of AI in cardiology.

Medicine

Health & Fitness

Rosu AI an initiative by Sun Pharma, presents its latest issue: “AI in Cardiology: The Clinical Foundation.” Artificial intelligence (AI) is rapidly transforming the landscape of cardiovascular medicine by enabling the analysis of large, complex datasets and uncovering patterns beyond conventional clinical approaches. In an era where cardiology is becoming increasingly data-intensive, AI-driven tools are supporting improved risk prediction, early disease detection, and more precise, individualized treatment strategies. In this edition of Rosu AI, we bring together key concepts, clinical applications, and future perspectives to help clinicians understand the evolving role of AI in cardiology.

Share AI in Heart Failure and Structural Heart Disease

Sign up to save your podcasts

AI in Heart Failure and Structural Heart Disease

AI in Heart Failure and Structural Heart Disease